Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-07-05
2010-02-16
Goddard, Laura B (Department: 1642)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S330000
Reexamination Certificate
active
07662776
ABSTRACT:
Where it was generally thought that the smallest breakdown products of proteins had no specific biological function on their own, it now emerges that the body may utilize the normal process of proteolytic breakdown to generate important compounds such as gene-regulatory or anti-tumor compounds. Such anti-tumor compounds are useful for the treatment or prevention of tumors and can be used as part of a pharmaceutical composition. The invention provides a pharmaceutical composition for the treatment of a subject suffering from or believed to be suffering from a tumor, said pharmaceutical composition comprising: a therapeutically effective amount of anti-tumor peptide or a functional analogue or derivative thereof together with a pharmaceutically acceptable diluent, wherein the peptide is preferably selected from the group VVC, LAG, AQG, LQGV (SEQ ID NO:1), QVVC (SEQ ID NO:), MTRV (SEQ ID NO:6), AQGV (SEQ ID NO:2), LAGV (SEQ ID NO:3), LQAV (SEQ ID NO:7), PGCP (SEQ ID NO:8), VGQL (SEQ ID NO:9), RVLQ (SEQ ID NO:10), EMFQ (SEQ ID NO:11), AVAL (SEQ ID NO:12), FVLS (SEQ ID NO:13), NMWD (SEQ ID NO:14), LCFL (SEQ ID NO:15), FSYA (SEQ ID NO:16), FWVD (SEQ ID NO:17), AFTV (SEQ ID NO:18), LGTL (SEQ ID NO:19), QLLG (SEQ ID NO:20), YAIT (SEQ ID NO:21), APSL (SEQ ID NO:22), ITTL (SEQ ID NO:23), QALG (SEQ ID NO:24), GVLC (SEQ ID NO:25), NLIN (SEQ ID NO:26), SPIE (SEQ ID NO:27), LNTI (SEQ ID NO:28), LHNL (SEQ ID NO:29), CPVQ (SEQ ID NO:30), EVVR (SEQ ID NO:31), MTEV (SEQ ID NO:32), EALE (SEQ ID NO:33), TLAVE (SEQ ID NO:38), VEGNL (SEQ ID NO:39), LNEAL (SEQ ID NO:40), VLPALP (SEQ ID NO:4), MGGTWA (SEQ ID NO:41), LTCDDP (SEQ ID NO:42), VLPALPQ (SEQ ID NO:43), VCNYRDV (SEQ ID NO:44), CPRGVNP (SEQ ID NO:45), QPLAPLVG (SEQ ID NO:46) or DINGFLPAL (SEQ ID NO:47).
REFERENCES:
patent: 4330466 (1982-05-01), Yanaihara et al.
patent: 4427660 (1984-01-01), Schiffman et al.
patent: 4571336 (1986-02-01), Houck et al.
patent: 4753965 (1988-06-01), Stemerick et al.
patent: 4855285 (1989-08-01), Stevens
patent: 4966848 (1990-10-01), Smith et al.
patent: 4977244 (1990-12-01), Muchmore et al.
patent: 5002961 (1991-03-01), Dage et al.
patent: 5010175 (1991-04-01), Rutter et al.
patent: 5055447 (1991-10-01), Palladino et al.
patent: 5102393 (1992-04-01), Sarnoff et al.
patent: 5223397 (1993-06-01), Pouletty
patent: 5223421 (1993-06-01), Smith et al.
patent: 5308834 (1994-05-01), Scott et al.
patent: 5380668 (1995-01-01), Herron
patent: 5436270 (1995-07-01), Wang
patent: 5677275 (1997-10-01), Lunardi-Iskandar et al.
patent: 5700781 (1997-12-01), Harris
patent: 5801193 (1998-09-01), Ojo-Amaize et al.
patent: 5837218 (1998-11-01), Peers et al.
patent: 5837478 (1998-11-01), Gallatin et al.
patent: 5851997 (1998-12-01), Harris
patent: 5854004 (1998-12-01), Czernilofsky et al.
patent: 5856440 (1999-01-01), Wang
patent: 5877148 (1999-03-01), Lunardi-Iskandar et al.
patent: 5942494 (1999-08-01), Ginsberg et al.
patent: 5958413 (1999-09-01), Anagnostopulos et al.
patent: 5966712 (1999-10-01), Sabatini et al.
patent: 5968513 (1999-10-01), Gallo et al.
patent: 5972924 (1999-10-01), Keep et al.
patent: 5981486 (1999-11-01), Matsushima et al.
patent: 5994126 (1999-11-01), Steinman et al.
patent: 5997871 (1999-12-01), Gallo et al.
patent: 6022696 (2000-02-01), Harding et al.
patent: 6051596 (2000-04-01), Badger
patent: 6075150 (2000-06-01), Wang et al.
patent: 6086918 (2000-07-01), Stern et al.
patent: 6150500 (2000-11-01), Salerno
patent: 6207145 (2001-03-01), Tovey
patent: 6235281 (2001-05-01), Stenzel et al.
patent: 6271199 (2001-08-01), Brand et al.
patent: 6278794 (2001-08-01), Parekh et al.
patent: 6309822 (2001-10-01), Fodor et al.
patent: 6310041 (2001-10-01), Haddox et al.
patent: 6319504 (2001-11-01), Gallo et al.
patent: 6329573 (2001-12-01), Lightfoot et al.
patent: 6361992 (2002-03-01), Szkudlinski et al.
patent: 6379970 (2002-04-01), Liebler et al.
patent: 6416959 (2002-07-01), Giuliano et al.
patent: 6489296 (2002-12-01), Grinnell et al.
patent: 6507788 (2003-01-01), Camara y Ferrer et al.
patent: 6518021 (2003-02-01), Thastrup et al.
patent: 6539102 (2003-03-01), Anderson et al.
patent: 6583109 (2003-06-01), Gallo et al.
patent: 6586403 (2003-07-01), Mathison et al.
patent: 6596688 (2003-07-01), Gallo et al.
patent: 6620416 (2003-09-01), Gallo et al.
patent: 6630138 (2003-10-01), Gerlitz et al.
patent: 6642201 (2003-11-01), Khavinson et al.
patent: 6645934 (2003-11-01), Rodemann et al.
patent: 6652860 (2003-11-01), Singh et al.
patent: 6699656 (2004-03-01), Gallo et al.
patent: 6711563 (2004-03-01), Koskas
patent: 6727227 (2004-04-01), Khavinson
patent: 6783757 (2004-08-01), Brudnak
patent: 6831057 (2004-12-01), Baldwin et al.
patent: 6844315 (2005-01-01), Khan et al.
patent: 6852697 (2005-02-01), Mathison et al.
patent: 6894028 (2005-05-01), Lipton et al.
patent: 6921751 (2005-07-01), Khan et al.
patent: 7094760 (2006-08-01), Mathison et al.
patent: 7135286 (2006-11-01), Margus et al.
patent: 7175679 (2007-02-01), Khan et al.
patent: 7316819 (2008-01-01), Grotts et al.
patent: 7358330 (2008-04-01), Khan et al.
patent: 7365155 (2008-04-01), Khan et al.
patent: 7368535 (2008-05-01), Ouspenski
patent: 7402322 (2008-07-01), Khan et al.
patent: 7501391 (2009-03-01), Khan et al.
patent: 7517529 (2009-04-01), Khan et al.
patent: 7560433 (2009-07-01), Khan et al.
patent: 2002/0041871 (2002-04-01), Brudnak
patent: 2002/0064501 (2002-05-01), Khan et al.
patent: 2002/0147306 (2002-10-01), Lin et al.
patent: 2002/0183255 (2002-12-01), Lipton et al.
patent: 2003/0017203 (2003-01-01), Crotts et al.
patent: 2003/0049273 (2003-03-01), Gallo et al.
patent: 2003/0113733 (2003-06-01), Khan et al.
patent: 2003/0119720 (2003-06-01), Khan et al.
patent: 2003/0166556 (2003-09-01), Khan et al.
patent: 2003/0186244 (2003-10-01), Margus et al.
patent: 2003/0215434 (2003-11-01), Khan et al.
patent: 2003/0219425 (2003-11-01), Khan et al.
patent: 2003/0220257 (2003-11-01), Benner et al.
patent: 2003/0220258 (2003-11-01), Benner et al.
patent: 2003/0220259 (2003-11-01), Benner et al.
patent: 2003/0220260 (2003-11-01), Khan et al.
patent: 2003/0220261 (2003-11-01), Khan et al.
patent: 2003/0224995 (2003-12-01), Khan et al.
patent: 2004/0013661 (2004-01-01), Wensvoort et al.
patent: 2004/0208885 (2004-10-01), Khan et al.
patent: 2005/0037430 (2005-02-01), Khan et al.
patent: 2005/0107314 (2005-05-01), Gorczynski et al.
patent: 2005/0214943 (2005-09-01), Khan et al.
patent: 2005/0227925 (2005-10-01), Benner et al.
patent: 2006/0111292 (2006-05-01), Khan et al.
patent: 2006/0142205 (2006-06-01), Benner et al.
patent: 2006/0173162 (2006-08-01), Djurup et al.
patent: 2006/0275255 (2006-12-01), Gudkov
patent: 2007/0111948 (2007-05-01), Turdiev
patent: 2007/0197447 (2007-08-01), Khan et al.
patent: 2008/0076714 (2008-03-01), Khan et al.
patent: 2008/0171094 (2008-07-01), Benner et al.
patent: 2008/0176243 (2008-07-01), Khan et al.
patent: 2008/0194489 (2008-08-01), Khan et al.
patent: 2008/0242618 (2008-10-01), Khan et al.
patent: 2008/0242837 (2008-10-01), Khan et al.
patent: 3715662 (1987-11-01), None
patent: 19953339 (2001-05-01), None
patent: 0 572 688 (1997-05-01), None
patent: 1 138 692 (2001-10-01), None
patent: 1 300 418 (2003-04-01), None
patent: 1 224 212 (2003-07-01), None
patent: 1 466 612 (2004-10-01), None
patent: 2 706 772 (1994-12-01), None
patent: 2 194 886 (1988-03-01), None
patent: 09-176187 (1997-07-01), None
patent: WO 9220795 (1992-11-01), None
patent: WO 96/04008 (1996-02-01), None
patent: WO 96/33218 (1996-10-01), None
patent: WO 97/49373 (1997-12-01), None
patent: WO 97/49418 (1997-12-01), None
patent: WO 97/49432 (1997-12-01), None
patent: WO 97/49721 (1997-12-01), None
patent: WO 98/06742 (1998-02-01), None
patent: WO 98/34631 (1998-08-01), None
patent: WO 98/35691 (1998-08-01), None
patent: WO 99/31227 (1999-06-01), None
patent: WO 99/59617 (1999-11-01), None
patent: WO 00/17348 (2000-03-01), None
patent: WO 01/10907 (2001-02-01), None
patent: WO 01/11048 (2001-02-01), None
patent: WO 0110457 (2001-02-01), None
patent: WO 01/29067 (2001-04-01), None
patent: WO 01/29069 (2001-04-01), None
patent: WO 01/32196 (2001-05-01), N
Benner Robbert
Khan Nisar A.
Wensvoort Gert
Biotempt B.V.
Goddard Laura B
TraskBritt
LandOfFree
Treatment of tumors using short peptides from human... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of tumors using short peptides from human..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of tumors using short peptides from human... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4168047